1,215
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Prevalence and covariates of uncontrolled hypertension in ischemic stroke survivors: the Norwegian stroke in the young study

, , , , , & show all
Pages 173-180 | Received 07 Nov 2017, Accepted 05 Jan 2018, Published online: 15 Jan 2018

References

  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–2128.
  • Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2014;45:2160–2236.
  • Samsa GP, Bian J, Lipscomb J, et al. Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke. 1999;30:338–349.
  • Putaala J, Curtze S, Hiltunen S, et al. Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40:2698–2703.
  • Jain S, Namboodri KK, Kumari S, et al. Loss of circadian rhythm of blood pressure following acute stroke. BMC Neurol. 2004;4:1.
  • Fromm A, Thomassen L, Naess H, et al. The Norwegian stroke in the young study (NOR-SYS): rationale and design. BMC Neurol. 2013;13:89.
  • Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.
  • 2013 ESH/ESC guidelines for the management of arterial hypertension. Blood Press. 2013;22:193–278.
  • O’Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: recommendations of the European society of hypertension. BMJ (Clinical Research Ed). 2001;322:531–536.
  • Van Bortel LM, Duprez D, Starmans-Kool MJ, et al. Clinical applications of arterial stiffness, task force III: recommendations for user procedures. Am J Hypertens. 2002;15:445–452.
  • Saeed S, Waje-Andreassen U, Fromm A, et al. Early vascular aging in young and middle-aged ischemic stroke patients: the Norwegian stroke in the young study. PLoS One. 2014;9:e112814.
  • McEniery CM, Yasmin Hall IR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753–1760.
  • Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34:290–296.
  • Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Intj Behav Med. 2012;19:403–488.
  • Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–3167.
  • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112:2735–2752.
  • Waje-Andreassen U, Thomassen L, Jusufovic M, et al. Ischaemic stroke at a young age is a serious event–final results of a population-based long-term follow-up in Western Norway. Eur J Neurol. 2013;20:818–823.
  • Aigner A, Grittner U, Rolfs A, et al. Contribution of established stroke risk factors to the burden of stroke in young adults. Stroke. 2017;48:1744–1751.
  • Cifkova R, Wohlfahrt P, Krajcoviechova A, et al. Blood pressure control and risk profile in poststroke survivors: a comparison with the general population. J Hypertens. 2015;33:2107–2114.
  • Paul SL, Thrift AG. Control of hypertension 5 years after stroke in the North East Melbourne stroke incidence study. Hypertension. 2006;48:260–265.
  • O’Brien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–1768.
  • Towfighi A, Markovic D, Ovbiagele B. Consistency of blood pressure control after ischemic stroke: prevalence and prognosis. Stroke. 2014;45:1313–1317.
  • Kesarwani M, Perez A, Lopez VA, et al. Cardiovascular comorbidities and blood pressure control in stroke survivors. J Hypertens. 2009;27:1056–1063.
  • Rutten-Jacobs LC, Arntz RM, Maaijwee NA, et al. Cardiovascular disease is the main cause of long-term excess mortality after ischemic stroke in young adults. Hypertension. 2015;65:670–675.
  • Sierra C, Domenech M, Camafort M, et al. Hypertension and mild cognitive impairment. Curr Hypertens Rep. 2012;14:548–555.
  • Gasecki D, Rojek A, Kwarciany M, et al. Pulse wave velocity is associated with early clinical outcome after ischemic stroke. Atherosclerosis. 2012;225:348–352.
  • Saeed S, Waje-Andreassen U, Lonnebakken MT, et al. Covariates of non-dipping and elevated night-time blood pressure in ischemic stroke patients: the Norwegian Stroke in the Young Study. Blood Press. 2016;25:212–218.
  • Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63:2935–2959.
  • Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 1993;88:1444–1455.
  • Alpert MA. Management of obesity cardiomyopathy. Am J Med Sci. 2001;321:237–241.
  • Gerdts E, de Simone G, Lund BP, et al. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. Nutr Metab Cardiovasc Dis. 2013;23:122–129.
  • Mancusi C, Gerdts E, Losi MA, et al. Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network). Int J Cardiol. 2017;244:260–264.
  • Lonnebakken MT, Izzo R, Mancusi C, et al. Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network). J Am Heart Assoc. 2017;6:e004152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.